middle.news
Proteomics International Secures Canadian Patent for Breakthrough Esophageal Cancer Test
8:32am on Friday 16th of January, 2026 AEDT
•
Healthcare
Read Story
Proteomics International Secures Canadian Patent for Breakthrough Esophageal Cancer Test
8:32am on Friday 16th of January, 2026 AEDT
Key Points
Canadian patent granted for PromarkerEso diagnostic test
Test detects esophageal adenocarcinoma early via blood biomarkers
Patent protection now spans Australia, Canada, China, Europe, Hong Kong, and the USA
Addresses critical unmet need with non-invasive alternative to costly endoscopy
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE